Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study

논문상세정보
' Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • ErbB receptors
  • Non–small cell lung carcinoma
  • Osimertinib
  • Real-world effectiveness
  • afatinib
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
33 0

0.0%